Therapeutic approach with mepolizumab (anti-IL-5) in a series of patients with eosinophilic granulomatosis with polyangiitis
N. Bizymi (Heraklion, Greece), A. Matthaiou (Heraklion, Greece), G. Stathakis (Heraklion, Greece), S. Viziriannaki (Heraklion, Greece), E. Bibaki (Heraklion, Greece), N. Tzanakis (Heraklion, Greece), K. Antoniou (Heraklion, Greece)
Source: International Congress 2022 – Asthma biologics in real life studies
Session: Asthma biologics in real life studies
Session type: Thematic Poster
Number: 2401
 
Rating: 
You must login to grade this presentation.
Share or cite this content
Citations should be made in the following way:
N. Bizymi (Heraklion, Greece), A. Matthaiou (Heraklion, Greece), G. Stathakis (Heraklion, Greece), S. Viziriannaki (Heraklion, Greece), E. Bibaki (Heraklion, Greece), N. Tzanakis (Heraklion, Greece), K. Antoniou (Heraklion, Greece). Therapeutic approach with mepolizumab (anti-IL-5) in a series of patients with eosinophilic granulomatosis with polyangiitis. 2401
You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
Related content which might interest you:
|
|